Intellia Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.6M | 441k | 17.27 |
| 2025-03-31 | $3.9M | 544k | 7.11 |
| 2024-12-31 | $6.5M | 559k | 11.66 |
| 2024-09-30 | $13M | 649k | 20.55 |
| 2024-06-30 | $15M | 669k | 22.38 |
| 2024-03-31 | $15M | 543k | 27.51 |
| 2023-12-31 | $19M | 636k | 30.49 |
| 2023-09-30 | $19M | 615k | 31.62 |
| 2023-06-30 | $27M | 653k | 40.78 |
| 2023-03-31 | $21M | 561k | 37.29 |
| 2022-12-31 | $23M | 663k | 35.06 |
| 2022-06-30 | $33M | 643k | 51.77 |
| 2022-03-31 | $46M | 628k | 72.68 |
| 2021-12-31 | $81M | 668k | 121.21 |
| 2021-03-31 | $72M | 902k | 80.27 |
| 2020-12-31 | $34M | 618k | 55.08 |
| 2020-09-30 | $9.3M | 428k | 21.63 |
| 2020-06-30 | $6.5M | 310k | 21.03 |
| 2020-03-31 | $2.7M | 224k | 12.22 |
| 2019-12-31 | $1.8M | 126k | 14.67 |
| 2019-09-30 | $169k | 13k | 13.33 |
| 2019-06-30 | $152k | 10k | 15.20 |
| 2019-03-31 | $138k | 8.1k | 17.02 |
| 2018-12-31 | $116k | 8.5k | 13.67 |
| 2018-09-30 | $220k | 7.7k | 28.59 |
| 2018-06-30 | $185k | 6.7k | 27.42 |
| 2018-03-31 | $590k | 28k | 21.16 |
| 2017-12-31 | $69k | 3.6k | 19.19 |
| 2017-03-31 | $47k | 3.3k | 14.23 |
| 2016-06-30 | $1.3M | 61k | 21.36 |